| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―24 |
SARS-CoV-2 Resistance to Small Molecule Inhibitors |
Uxua Modrego Lopez, Md. Mehedi Hasan, Brandon Havranek, Shahidul M. Islam |
| 2 |
[GO] |
2023―Nov―14 |
Engineered Therapeutic Antibody Against SARS-CoV-2 |
Monrat Chulanetra |
| 3 |
[GO] |
2023―Jun―24 |
The Role of the Oxidative Stress-Inflammation Axis in the COVID-19-Infected Patients with Chagas Disease: A Key Parameter To Be Considered During the Pandemic |
Duygu Aydemir, Nuriye Nuray Ulusu |
| 4 |
[GO] |
2022―Nov―03 |
When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection |
Harnoor Singh Pruthi |
| 5 |
[GO] |
2022―Apr―09 |
Comparison of Survival and Clinical Profile of Adults with COVID-19 Hospitalized in Two Clinics in Medellín, Colombia |
Juan Carlos Cataño-Correa, Jaiberth Antonio Cardona-Arias, Jessica Paola Porras-Mancilla, Marcela Tabares-García |
| 6 |
[GO] |
2021―Jul―03 |
A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants? |
Rashed Noor |
| 7 |
[GO] |
2021―Jul―03 |
COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks |
Rashed Noor, Nishat Tasnim, Chandrika Saha |
| 8 |
[GO] |
2021―Mar―05 |
Cardiovascular Injury Due to SARS-CoV-2 |
Christina L. Bugert, Victoria Kwiat, Isela C. Valera, Joachim J. Bugert, Michelle S. Parvatiyar |
| 9 |
[GO] |
2021―Mar―03 |
Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines |
Rashed Noor |
| 10 |
[GO] |
2021―Feb―18 |
COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development |
Sabhiya Majid, Mosin S. Khan, Samia Rashid, Ayesha Niyaz, Rabia Farooq, Showkat A. Bhat, Hilal A. Wani, Waseem Qureshi |
